The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

HOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 V ...

After failing to hit the primary endpoint in a Phase III trial, Neumora is remixing study parameters in two replicate trials, with data expected in the first half of 2026. Neumora Therapeutics has ...

CAIRO, March 2 (Reuters) - Hamas will not agree to extend the first phase of the Gaza ceasefire deal as requested by Israel, a senior Hamas official said Sunday. Speaking to Al Jazeera ...

CAIRO (AP) — Israel’s government said early Sunday it supports a proposal to extend the first phase of the ceasefire in Gaza through Ramadan and Passover, though Hamas has insisted on ...

Phase 2 trials are underway in two parts. The first, which has been classified as 2A, is the 9.77-kilometre stretch from Dharavi to Acharya Atrey Chowk MMRC said in a press note that system trials for ...

It starts from day one of your period and goes on till the time your next one arrives. The follicular phase is the one that takes up the first half of your menstrual cycle. Read on to know more about ...

The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...